IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,957,656 | -28.0% | 3,287,397 | +11.4% | 3.99% | -4.5% |
| Q2 2023 | $20,768,831 | +30.0% | 2,950,118 | +12.8% | 4.18% | +0.7% |
| Q1 2023 | $15,977,509 | +16.3% | 2,614,977 | +21.7% | 4.15% | +16.5% |
| Q4 2022 | $13,735,625 | -15.7% | 2,149,550 | +26.4% | 3.56% | -7.6% |
| Q3 2022 | $16,286,000 | +22.9% | 1,700,000 | +41.7% | 3.86% | +4.8% |
| Q2 2022 | $13,248,000 | – | 1,200,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
| Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
| Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
| Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
| Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
| Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
| Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
| Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
| COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |